295 related articles for article (PubMed ID: 34235592)
1. Vaccination of cancer patients against COVID-19: towards the end of a dilemma.
Mandal A; Singh P; Samaddar A; Singh D; Verma M; Rakesh A; Ranjan R
Med Oncol; 2021 Jul; 38(8):92. PubMed ID: 34235592
[TBL] [Abstract][Full Text] [Related]
2. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
Li Q; Wang J; Tang Y; Lu H
Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
[TBL] [Abstract][Full Text] [Related]
3. Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.
Romano E; Pascolo S; Ott P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117117
[TBL] [Abstract][Full Text] [Related]
4. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
[TBL] [Abstract][Full Text] [Related]
5. [COVID-19 vaccination for cancer patients: Medical and ethical need].
Spano JP; Barre-Sinoussi F; Kieny MP; Marcelin AG; Blay JY
Bull Cancer; 2021 Mar; 108(3):225-227. PubMed ID: 33674059
[No Abstract] [Full Text] [Related]
6. Fake COVID-19 vaccines: scams hampering the vaccination drive in India and possibly other countries.
Choudhary OP; Priyanka ; Singh I; Mohammed TA; Rodriguez-Morales AJ
Hum Vaccin Immunother; 2021 Nov; 17(11):4117-4118. PubMed ID: 34357851
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai A; Gainor JF; Hegde A; Schram AM; Curigliano G; Pal S; Liu SV; Halmos B; Groisberg R; Grande E; Dragovich T; Matrana M; Agarwal N; Chawla S; Kato S; Morgan G; Kasi PM; Solomon B; Loong HH; Park H; Choueiri TK; Subbiah IM; Pemmaraju N; Subbiah V;
Nat Rev Clin Oncol; 2021 May; 18(5):313-319. PubMed ID: 33723371
[TBL] [Abstract][Full Text] [Related]
8. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
10. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccination: the VOICE for patients with cancer.
van der Veldt AAM; Oosting SF; Dingemans AC; Fehrmann RSN; GeurtsvanKessel C; Jalving M; Rimmelzwaan GF; Kvistborg P; Blank CU; Smit EF; Lemmens VEEP; Hiltermann TJN; Koopmans MPG; Huckriede ALW; Rots NY; van Els CACM; van Baarle D; Haanen JBAG; de Vries EGE
Nat Med; 2021 Apr; 27(4):568-569. PubMed ID: 33589821
[No Abstract] [Full Text] [Related]
12. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
Elife; 2021 Oct; 10():. PubMed ID: 34636722
[TBL] [Abstract][Full Text] [Related]
13. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.
Xu W; Su S; Jiang S
Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979
[No Abstract] [Full Text] [Related]
14. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
15. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
She J; Hou D; Chen C; Bi J; Song Y
Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
[TBL] [Abstract][Full Text] [Related]
16. Fight against hesitancy: public health concern towards COVID-19 vaccine.
Punsalan MLD
J Public Health (Oxf); 2021 Jun; 43(2):e372. PubMed ID: 33730162
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.
Sayed S
Cancer Treat Res Commun; 2021; 28():100425. PubMed ID: 34171559
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
Carr E
Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
[TBL] [Abstract][Full Text] [Related]
20. Targets and strategies for vaccine development against SARS-CoV-2.
Malik JA; Mulla AH; Farooqi T; Pottoo FH; Anwar S; Rengasamy KRR
Biomed Pharmacother; 2021 May; 137():111254. PubMed ID: 33550049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
